$EBZT
Everything Blockchain, Inc.

2022 Q4 Form 10-Q Financial Statement

#000147793222009419 Filed on December 20, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q2 2021 Q4
Revenue $1.822M $255.0K $4.906M
YoY Change -62.86% -76.41% 7812.9%
Cost Of Revenue $1.475M $15.00K $723.0K
YoY Change 104.01%
Gross Profit $347.0K $240.0K $4.183M
YoY Change -91.7% -77.8% 6646.77%
Gross Profit Margin 19.05% 94.12% 85.26%
Selling, General & Admin $996.0K $1.093M $898.0K
YoY Change 10.91% 680.71% 33.23%
% of Gross Profit 287.03% 455.42% 21.47%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $50.00K $40.00K
YoY Change
% of Gross Profit 20.83% 0.96%
Operating Expenses $1.752M $1.946M $938.0K
YoY Change 86.78% 1290.0% 39.17%
Operating Profit -$1.405M -$1.706M $3.245M
YoY Change -143.3% -281.3% -630.23%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net -$246.0K -$160.0K -$15.00K
YoY Change 1540.0% -174.77% -103.17%
Pretax Income -$1.669M -$1.866M $3.230M
YoY Change -151.67% -343.29% -2414.25%
Income Tax $405.0K $412.0K $0.00
% Of Pretax Income 0.0%
Net Earnings -$1.264M -$1.454M $3.230M
YoY Change -139.13% -289.57% -2407.14%
Net Earnings / Revenue -69.37% -570.2% 65.84%
Basic Earnings Per Share -$0.13 -$0.17 $0.38
Diluted Earnings Per Share -$0.13 -$0.17 $0.29
COMMON SHARES
Basic Shares Outstanding 9.676M shares 8.666M shares 8.553B shares
Diluted Shares Outstanding 9.676M shares 8.666M shares 11.30M shares

Balance Sheet

Concept 2022 Q4 2022 Q2 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.699M $1.546M
YoY Change 4043.9% 2208471.43%
Cash & Equivalents $882.0K $1.699M $1.546M
Short-Term Investments
Other Short-Term Assets $113.0K $53.00K $8.653M
YoY Change -98.69% -97.45% 21355.49%
Inventory $65.00K $83.00K $60.00K
Prepaid Expenses $2.741M $2.750M $3.183M
Receivables $222.0K $58.00K $147.0K
Other Receivables $0.00 $0.00
Total Short-Term Assets $4.028M $7.675M $10.41M
YoY Change -61.29% 246.03% 25651.05%
LONG-TERM ASSETS
Property, Plant & Equipment $822.0K $971.0K $939.0K
YoY Change -12.46% 316.74%
Goodwill $17.82M $17.82M $1.319M
YoY Change 1251.25%
Intangibles $7.473M
YoY Change
Long-Term Investments
YoY Change
Other Assets $463.0K $3.000K
YoY Change
Total Long-Term Assets $24.04M $22.68M $9.734M
YoY Change 146.96% 1223.7% 526.77%
TOTAL ASSETS
Total Short-Term Assets $4.028M $7.675M $10.41M
Total Long-Term Assets $24.04M $22.68M $9.734M
Total Assets $28.07M $30.35M $20.14M
YoY Change 39.36% 672.07% 1163.92%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $154.0K $154.0K
YoY Change 0.0% -0.2%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change -100.0% -100.0%
Long-Term Debt Due $283.0K $282.0K $281.0K
YoY Change 0.71%
Total Short-Term Liabilities $2.404M $1.708M $822.0K
YoY Change 192.46% 12.0% 176.58%
LONG-TERM LIABILITIES
Long-Term Debt $246.0K $263.0K $280.0K
YoY Change -12.14%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $246.0K $466.0K $280.0K
YoY Change -12.14%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.404M $1.708M $822.0K
Total Long-Term Liabilities $246.0K $466.0K $280.0K
Total Liabilities $2.650M $2.174M $1.102M
YoY Change 140.47% 42.56% 270.79%
SHAREHOLDERS EQUITY
Retained Earnings -$56.48M -$52.55M -$46.87M
YoY Change 20.49%
Common Stock $1.000K $1.000K $1.000K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $1.691M $1.598M
YoY Change 5.82%
Treasury Stock Shares
Shareholders Equity $25.42M $28.18M $19.04M
YoY Change
Total Liabilities & Shareholders Equity $28.07M $30.35M $20.14M
YoY Change 39.36% 672.07% 1163.92%

Cashflow Statement

Concept 2022 Q4 2022 Q2 2021 Q4
OPERATING ACTIVITIES
Net Income -$1.264M -$1.454M $3.230M
YoY Change -139.13% -289.57% -2407.14%
Depreciation, Depletion And Amortization $50.00K $40.00K
YoY Change
Cash From Operating Activities -$536.0K -$2.794M
YoY Change -138.45% -6189.8%
INVESTING ACTIVITIES
Capital Expenditures -$319.0K -$137.0K
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $3.659M
YoY Change -100.0%
Cash From Investing Activities -$319.0K $3.522M
YoY Change -83.67%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $1.492M -1.000K
YoY Change 148.67% -97.82%
NET CHANGE
Cash From Operating Activities -$536.0K -2.794M
Cash From Investing Activities -$319.0K 3.522M
Cash From Financing Activities $1.492M -1.000K
Net Change In Cash $637.0K 727.0K
YoY Change 1453.66% -1817600.0%
FREE CASH FLOW
Cash From Operating Activities -$536.0K -$2.794M
Capital Expenditures -$319.0K -$137.0K
Free Cash Flow -$217.0K -$2.657M
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
25417000 usd
CY2022Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
0 usd
CY2022Q4 us-gaap Assets
Assets
28067000 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1686000 usd
CY2022Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
744000 usd
CY2022Q1 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
24000 usd
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
283000 usd
CY2022Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
282000 usd
CY2022Q4 ebi Reserves For Legal Settlements
ReservesForLegalSettlements
154000 usd
CY2022Q1 ebi Reserves For Legal Settlements
ReservesForLegalSettlements
154000 usd
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
281000 usd
CY2022Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
108000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2404000 usd
CY2022Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
617000 usd
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
246000 usd
CY2022Q1 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
1062000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
2650000 usd
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8604038 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
1000 usd
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
983000 usd
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
1691000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
83834000 usd
CY2021Q4 us-gaap Revenues
Revenues
830000 usd
us-gaap Revenues
Revenues
2460000 usd
us-gaap Revenues
Revenues
2216000 usd
us-gaap Cost Of Revenue
CostOfRevenue
1546000 usd
us-gaap Gross Profit
GrossProfit
2006000 usd
CY2021Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
898000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3068000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1725000 usd
CY2021Q4 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
0 usd
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
2197000 usd
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
0 usd
CY2021Q4 us-gaap Depreciation And Amortization
DepreciationAndAmortization
40000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
140000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
63000 usd
CY2021Q4 us-gaap Operating Expenses
OperatingExpenses
938000 usd
us-gaap Operating Expenses
OperatingExpenses
5405000 usd
us-gaap Operating Expenses
OperatingExpenses
1788000 usd
CY2021Q4 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-294000 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-4491000 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
218000 usd
CY2021Q4 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
3524000 usd
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-2494000 usd
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
6319000 usd
CY2021Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
3230000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-6985000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
6537000 usd
CY2021Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1599000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
3230000 usd
us-gaap Net Income Loss
NetIncomeLoss
-5386000 usd
us-gaap Net Income Loss
NetIncomeLoss
6537000 usd
CY2021Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.38
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.58
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.92
dei Entity Central Index Key
EntityCentralIndexKey
0001730869
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--01-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-10-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-56142
dei Entity Registrant Name
EntityRegistrantName
Everything Blockchain, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
82-1091922
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-56477000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
28067000 usd
CY2022Q4 us-gaap Revenues
Revenues
1822000 usd
dei Entity Address Address Line1
EntityAddressAddressLine1
12574 Flagler Center Blvd
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 101
dei Entity Address City Or Town
EntityAddressCityOrTown
Jacksonville
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
32258
dei City Area Code
CityAreaCode
904
dei Local Phone Number
LocalPhoneNumber
454-2111
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
9923304 shares
CY2022Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
882000 usd
CY2022Q4 ebi Current Cryptocurrencies Net
CurrentCryptocurrenciesNet
5000 usd
CY2022Q4 ebi Intangible Assets Non Current
IntangibleAssetsNonCurrent
3948000 usd
CY2022Q1 ebi Intangible Assets Non Current
IntangibleAssetsNonCurrent
3119000 usd
CY2022Q4 us-gaap Other Assets
OtherAssets
463000 usd
CY2022Q1 us-gaap Other Assets
OtherAssets
463000 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
0 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9949966 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9923304 shares
CY2022Q4 ebi Receivable From Stockholder
ReceivableFromStockholder
-250000 usd
CY2022Q4 us-gaap Cost Of Revenue
CostOfRevenue
1475000 usd
CY2021Q4 us-gaap Cost Of Revenue
CostOfRevenue
186000 usd
CY2022Q4 us-gaap Gross Profit
GrossProfit
347000 usd
CY2022Q4 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
716000 usd
CY2022Q4 us-gaap Depreciation And Amortization
DepreciationAndAmortization
40000 usd
CY2022Q4 us-gaap Operating Expenses
OperatingExpenses
1752000 usd
CY2022Q4 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-1405000 usd
CY2022Q4 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-264000 usd
CY2022Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-1669000 usd
CY2022Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
405000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-1264000 usd
CY2021Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11304831 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9258102 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9445111 shares
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
CY2022Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.13
CY2021Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.29
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.58
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.69
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9676492 shares
CY2021Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8552786 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9258102 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7074748 shares
CY2022Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9676492 shares
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
1539000 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
669000 usd
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
1109000 usd
us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
8642000 usd
ebi Stockissued During Period Value Issued For Warrants Exercises
StockissuedDuringPeriodValueIssuedForWarrantsExercises
140000 usd
ebi Issuance Of Series A Preferred For Services Amount
IssuanceOfSeriesAPreferredForServicesAmount
2000000 usd
ebi Conversion Of Note Receivable Amount
ConversionOfNoteReceivableAmount
-1598000 usd
us-gaap Net Income Loss
NetIncomeLoss
6537000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
27445000 usd
ebi Issuance Of Series C Preferred Amount
IssuanceOfSeriesCPreferredAmount
1000000 usd
ebi Conversion Of Series C Preferred Into Common Stock Amount
ConversionOfSeriesCPreferredIntoCommonStockAmount
0 usd
ebi Stockissued During Period Value Issued For Warrants Exercises
StockissuedDuringPeriodValueIssuedForWarrantsExercises
535000 usd
ebi Sale Of Asset Amount
SaleOfAssetAmount
-92000 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1915000 usd
us-gaap Net Income Loss
NetIncomeLoss
-5386000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
25417000 usd
us-gaap Profit Loss
ProfitLoss
-5386000 usd
us-gaap Profit Loss
ProfitLoss
6537000 usd
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
2197000 usd
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
0 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1601000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 usd
ebi Reverse Of Bad Debt
ReverseOfBadDebt
0 usd
ebi Reverse Of Bad Debt
ReverseOfBadDebt
-233000 usd
ebi Net Loss On Exchanges
NetLossOnExchanges
4000 usd
ebi Net Loss On Exchanges
NetLossOnExchanges
0 usd
ebi Realized Net Gain Loss On Investment In Cryptocurrency
RealizedNetGainLossOnInvestmentInCryptocurrency
186000 usd
us-gaap Interest Income Purchased Receivables
InterestIncomePurchasedReceivables
32000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-5000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-61000 usd
ebi Conversion Of Stocks Shares Issued1
ConversionOfStocksSharesIssued1
40000 usd
ebi Trade In Of Vehicle
TradeInOfVehicle
3000 usd
ebi Realized Net Gain Loss On Investment In Cryptocurrency
RealizedNetGainLossOnInvestmentInCryptocurrency
-3382000 usd
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 usd
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
16000 usd
us-gaap Assets Fair Value Adjustment
AssetsFairValueAdjustment
2206000 usd
us-gaap Assets Fair Value Adjustment
AssetsFairValueAdjustment
-4685000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
140000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
63000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-211000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-114000 usd
us-gaap Interest Income Purchased Receivables
InterestIncomePurchasedReceivables
0 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-104000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-72000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-69000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-4000 usd
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-30000 usd
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
12000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
977000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
93000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
173000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-155000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1523000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2017000 usd
ebi Acquisition Of Cryptocurrencies Net
AcquisitionOfCryptocurrenciesNet
1264000 usd
us-gaap Proceeds From Sale Of Longterm Investments
ProceedsFromSaleOfLongtermInvestments
755000 usd
us-gaap Proceeds From Sale Of Longterm Investments
ProceedsFromSaleOfLongtermInvestments
4729000 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
23000 usd
us-gaap Payments To Acquire Assets Investing Activities
PaymentsToAcquireAssetsInvestingActivities
888000 usd
us-gaap Payments To Acquire Assets Investing Activities
PaymentsToAcquireAssetsInvestingActivities
137000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-133000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
3305000 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
0 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
500000 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
24000 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
10000 usd
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
1000000 usd
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
0 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
500000 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
768000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1476000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
258000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-180000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
1546000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1062000 usd
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
882000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1546000 usd
us-gaap Interest Paid Net
InterestPaidNet
42000 usd
us-gaap Interest Paid Net
InterestPaidNet
19000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
3000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
ebi Conversion Of Stocks Shares Issued1
ConversionOfStocksSharesIssued1
35000 usd
ebi Trade In Of Vehicle
TradeInOfVehicle
0 usd
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
92000 usd
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
0 usd
ebi Exercise Of Warrant For Receivable
ExerciseOfWarrantForReceivable
250000 usd
ebi Exercise Of Warrant For Receivable
ExerciseOfWarrantForReceivable
0 usd
us-gaap Proceeds From Loans
ProceedsFromLoans
0 usd
us-gaap Proceeds From Loans
ProceedsFromLoans
500000 usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
0 usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
240000 usd
us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
0 usd
us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
9433000 usd
us-gaap Liabilities Fair Value Adjustment
LiabilitiesFairValueAdjustment
0 usd
us-gaap Liabilities Fair Value Adjustment
LiabilitiesFairValueAdjustment
791000 usd
us-gaap Payments To Acquire Receivables
PaymentsToAcquireReceivables
0 usd
us-gaap Payments To Acquire Receivables
PaymentsToAcquireReceivables
233000 usd
ebi Conversion Of Note Receivable In Exchange For Common Stock And Preferred Stock
ConversionOfNoteReceivableInExchangeForCommonStockAndPreferredStock
0 usd
ebi Conversion Of Note Receivable In Exchange For Common Stock And Preferred Stock
ConversionOfNoteReceivableInExchangeForCommonStockAndPreferredStock
1598000 usd
ebi Stock Issued During Period Value Issued For Services1
StockIssuedDuringPeriodValueIssuedForServices1
0 usd
ebi Stock Issued During Period Value Issued For Services1
StockIssuedDuringPeriodValueIssuedForServices1
1110000 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
0 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
2000000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, and disclosures of contingent assets and liabilities as of the date of the consolidated financial statements and reported amounts of revenues and expenses during the reporting period. Management bases its estimates on historical experience and on various assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. The most significant estimates and judgments relate to revenue recognition; sales returns and other allowances; allowance for doubtful accounts; valuation of inventory; valuation and recoverability of long-lived assets; property and equipment; contingencies; and income taxes.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On a regular basis, management reviews its estimates utilizing currently available information, changes in facts and circumstances, historical experience and reasonable assumptions. After such reviews, and if deemed appropriate, those estimates are adjusted accordingly. Actual results could differ from those estimates.</p>
CY2022Q4 us-gaap Loans Payable Current
LoansPayableCurrent
0 usd
CY2022Q1 us-gaap Loans Payable Current
LoansPayableCurrent
24000 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Financial instruments which potentially subject the Company to a concentration of credit risk consist principally of temporary cash investments and accounts receivable. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Concentrations of credit risk with respect to trade receivables and commodities are limited due to the Company’s diverse group of customers. The Company establishes an allowance for doubtful accounts when events and circumstances regarding the collectability of its receivables or the selling of its commodities warrant based upon factors such as the credit risk of specific customers, historical trends, other information and past bad debt history. The outstanding balances are stated net of an allowance for doubtful accounts.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Revenues from one customer represent $1.0 million of the Company’s revenue for the nine months ended October 31, 2021.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Our cash balances are maintained in accounts held by major banks and financial institutions located in the United States. The Company may occasionally maintain amounts on deposit with a financial institution that are in excess of the federally insured limit of $250,000. The risk is managed by maintaining all deposits in high-quality financial institutions. The Company had $0.6 million and $0.1 million in excess of federally insured limits on October 31, 2022 and January 31, 2022, respectively.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Our cryptocurrency balances are maintained in accounts held by institutions located in and outside the United States. The Company maintains amounts on deposit that often exceed coverage from third party insured limit of up to $1,000,000. The risk is managed by maintaining multiple accounts with various accounts held in a cold storage wallet. The Company had $4,000 in excess of amounts protected by insurance on October 31, 2022. </p>
CY2022Q4 ebi Federally Insured Limit
FederallyInsuredLimit
250000 usd
CY2022Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
600000 usd
CY2022Q1 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
100000 usd
CY2022Q4 ebi Third Party Insured Limit
ThirdPartyInsuredLimit
1000000 usd
CY2022Q4 us-gaap Life Insurance Corporate Or Bank Owned Amount
LifeInsuranceCorporateOrBankOwnedAmount
4000 usd
CY2022Q3 ebi Sale Of Stock Number Of Shares Issued In Transaction1
SaleOfStockNumberOfSharesIssuedInTransaction1
10000000 shares
CY2022Q3 ebi Salaes Consideration
SalaesConsideration
450000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
4001000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
53000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
3948000 usd
CY2022Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3142000 usd
CY2022Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
23000 usd
CY2022Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
3119000 usd
CY2022Q4 ebi Fair Value Market Price
FairValueMarketPrice
5000 usd
CY2022Q1 ebi Fair Value Market Price
FairValueMarketPrice
3152000 usd
CY2022Q4 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
200000 usd
us-gaap Equity Fair Value Adjustment
EquityFairValueAdjustment
2200000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
200000 usd
CY2021Q4 us-gaap Equity Fair Value Adjustment
EquityFairValueAdjustment
2300000 usd
CY2021Q4 ebi Net Of Associated Costs
NetOfAssociatedCosts
1200000 usd
us-gaap Equity Fair Value Adjustment
EquityFairValueAdjustment
4700000 usd
ebi Net Of Associated Costs
NetOfAssociatedCosts
1400000 usd
ebi Loss On Sale Of Security
LossOnSaleOfSecurity
47000 usd
CY2022Q3 ebi Sale Of Hex Token
SaleOfHexToken
6700000 shares
CY2022Q3 ebi Salaes Consideration
SalaesConsideration
304747 usd
us-gaap Trading Gains Losses
TradingGainsLosses
195000 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
969000 usd
CY2022Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1061000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
147000 usd
CY2022Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
60000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
822000 usd
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1001000 usd
CY2022Q4 ebi Outstanding Debt
OutstandingDebt
500000 usd
CY2022Q4 us-gaap Debt Weighted Average Interest Rate
DebtWeightedAverageInterestRate
0.063 pure
ebi Debt Maturity Range
DebtMaturityRange
2022 through 2037
CY2022Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
2000000 usd
CY2022Q1 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
2000000 usd
CY2022Q4 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
0 usd
CY2022Q1 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
24000 usd
CY2022Q4 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
6000 usd
CY2022Q1 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
0 usd
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9949966 shares
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8604038 shares
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9923304 shares
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8604038 shares
CY2022Q2 ebi Warrants Exercised
WarrantsExercised
500000 usd
CY2022Q2 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
500000 usd
CY2022Q4 us-gaap Extended Product Warranty Accrual
ExtendedProductWarrantyAccrual
250000 usd
CY2022Q4 ebi Common Stock Resulting In The Company Receivable
CommonStockResultingInTheCompanyReceivable
300000 usd
CY2022Q4 us-gaap Share Based Compensation
ShareBasedCompensation
75000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
281000 usd
us-gaap Payments To Employees
PaymentsToEmployees
225000 usd
ebi Payment To Consultants
PaymentToConsultants
56000 usd
CY2022Q2 us-gaap Common Stock Dividends Shares
CommonStockDividendsShares
250000 shares
CY2022Q2 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
1000000.0 usd
CY2022Q2 us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
250000 shares
CY2022Q2 us-gaap Stock Issued During Period Shares Conversion Of Units
StockIssuedDuringPeriodSharesConversionOfUnits
560928 shares
CY2022Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
500000 shares
CY2022Q2 us-gaap Cash
Cash
500000 usd
CY2022Q4 ebi Series B Preferred Stock
SeriesBPreferredStock
250000 shares
CY2022Q4 ebi Common Stock
CommonStock
26662 shares
CY2022Q4 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.26 pure
us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.23 pure
CY2022Q4 us-gaap Profit Loss
ProfitLoss
-1264000 usd
CY2021Q4 us-gaap Profit Loss
ProfitLoss
3230000 usd
us-gaap Profit Loss
ProfitLoss
-5386000 usd
us-gaap Profit Loss
ProfitLoss
6537000 usd
CY2022Q4 us-gaap Weighted Average Basic Shares Outstanding Pro Forma
WeightedAverageBasicSharesOutstandingProForma
9676000 shares
CY2021Q4 us-gaap Weighted Average Basic Shares Outstanding Pro Forma
WeightedAverageBasicSharesOutstandingProForma
8553000 shares
us-gaap Weighted Average Basic Shares Outstanding Pro Forma
WeightedAverageBasicSharesOutstandingProForma
9258000 shares
us-gaap Weighted Average Basic Shares Outstanding Pro Forma
WeightedAverageBasicSharesOutstandingProForma
7075000 shares
CY2021Q4 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
2752000 shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
2370000 shares
CY2022Q4 ebi Diluted Shares Outstanding
DilutedSharesOutstanding
9676000 shares
CY2021Q4 ebi Diluted Shares Outstanding
DilutedSharesOutstanding
11305000 shares
ebi Diluted Shares Outstanding
DilutedSharesOutstanding
9258000 shares
ebi Diluted Shares Outstanding
DilutedSharesOutstanding
9445000 shares
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
CY2021Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.38
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.58
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.92
CY2022Q4 ebi Diluted Net Income Loss Per Common Share
DilutedNetIncomeLossPerCommonShare
-0.13
CY2021Q4 ebi Diluted Net Income Loss Per Common Share
DilutedNetIncomeLossPerCommonShare
0.29
ebi Diluted Net Income Loss Per Common Share
DilutedNetIncomeLossPerCommonShare
-0.58
ebi Diluted Net Income Loss Per Common Share
DilutedNetIncomeLossPerCommonShare
0.69

Files In Submission

Name View Source Status
0001477932-22-009419-index-headers.html Edgar Link pending
0001477932-22-009419-index.html Edgar Link pending
0001477932-22-009419.txt Edgar Link pending
0001477932-22-009419-xbrl.zip Edgar Link pending
ebi-20221031.xsd Edgar Link pending
ebi_10q.htm Edgar Link pending
ebi-20221031_cal.xml Edgar Link unprocessable
ebi-20221031_def.xml Edgar Link unprocessable
ebi-20221031_pre.xml Edgar Link unprocessable
ebi_10q_htm.xml Edgar Link completed
ebi_ex311.htm Edgar Link pending
ebi_ex312.htm Edgar Link pending
ebi_ex321.htm Edgar Link pending
ebi_ex322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ebi-20221031_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable